Model
Edge
Nabriva Therapeutics
0001732196
Filing Type
4
Filing Date
7/29/2021
Updated
7/30/21, 2:17 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership